FDA approves new erectile dysfunction drug
April 30, 2012Sales and Marketing ED, FDA, Stendra. Pfizer, Vivus, viagra
The FDA has approved Vivus’ erectile dysfunction drug Stendra, and the firm hopes its rapid mode of action will help …
NICE no to GSK’s lupus drug Benlysta
April 27, 2012Sales and Marketing Andrew Dillon, Benlysta, GSK, Lupus, NICE
NICE is still not recommending GlaxoSmithKline’s lupus drug Benlysta, as it believes the treatment is too costly. In its final …
Novartis right to challenge NHS on Avastin use – ABPI chief
April 27, 2012Sales and Marketing ABPI, Lucentis, Whitehead, avastin, wet AMD
The ABPI has declared its support for Novartis in its legal challenge against off-label prescribing in England.The pharma company is …
New head at Bayer’s Animal Health division
April 27, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer Healthcare, Dirk Ehle, animal health
Dr Dirk Ehle has been appointed Head of the Animal Health Division of Bayer. The 42-year-old succeeds Dr Jean-Luc Lowinski, …
Watson buys Actavis to create generics giant
April 27, 2012Sales and Marketing Actavis, Watson, generics
Watson Pharmaceuticals is to buy rival Actavis Group in a move that will create the third largest generics manufacturer in …
Brennan bows to pressure and quits AstraZeneca
April 26, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, David Brennan, Q1, pharma
AstraZeneca’s chief executive David Brennan is to step down from his post following mounting dissatisfaction with his leadership. Brennan, who …
Novartis Q1 earnings slide down
April 26, 2012Sales and Marketing Novartis, Q1, Sandoz, generics, gilenya
Generic competition and problems at a US plant were among the reasons why Novartis’ sales and profit dipped in the …
Text message prompts ‘improve medicines adherence’
April 26, 2012Medical Communications SMS, Text messages, digital communications, medicines adherence
Patients with long-term diseases benefit from having text message reminders to take their medication. This is according to a new …
Two new hep C pills recommended by NICE
April 25, 2012Sales and Marketing Incivo, Janssen, MSD, NICE, Victrelis, hep C
NICE has given its final recommendation for two new hepatitis C pills in an expedited review. Janssen’s Incivo (telaprevir) and …
A family business: Pradaxa success lifts Boehringer
April 25, 2012Research and Development, Sales and Marketing Boehringer Ingelheim
Rapid uptake of anti-clotting drug Pradaxa in the US has helped Boehringer Ingelheim enjoy a strong year, and looks set to …
GMC won’t relax off-label prescribing guidelines
April 25, 2012Sales and Marketing GMC, Lucentis, Novartis, Roche, avastin, off label, off-label
The GMC has decided not to relax guidelines on off-label prescribing when a licensed alternative exists. The GMC’s current rules …
Paul Mannu joins Insight Research Group as consultant
April 25, 2012Business Services, Medical Communications, Sales and Marketing Cello, Insight Research Group
Paul Mannu has joined the senior research team at Insight Research Group as a consultant. For the last few years Paul …
Merck KGaA swings axe over Serono operations
April 25, 2012Manufacturing and Production, Research and Development, Sales and Marketing Cladribine, MS, Merck KGaA, Switzerland, job cuts
Merck KGaA will cut around 500 jobs from its pharmaceutical unit in Switzerland, the firm has announced. The company said …
New data shows Herceptin’s ability to increase survival
April 24, 2012Research and Development, Sales and Marketing Cancer, Cochrane, Herceptin, Roche, breast
A new review of Roche’s breast cancer drug Herceptin has confirmed its ability to increase overall survival, but concerns remain …
Shire’s Vpriv website in breach of ABPI Code
April 24, 2012Medical Communications, Sales and Marketing ABPI, Genzyme, PMCPA, Shire, Vpriv, code
Shire’s website for its Gaucher’s disease drug Vpriv has fallen foul of the ABPI’s Code of Conduct. The complaint was …
Novartis to invest $550m in new Swiss plant
April 24, 2012Manufacturing and Production GSK, Novartis, manufacturing and production
Novartis has unveiled plans to build a new manufacturing facility at its site in Stein, Switzerland, just weeks after calling …
7 steps to better talent acquisition
April 24, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, Talent acquisition, careers, executives
When companies complain that they can’t find enough good people, the cause, in our view, is most likely to be …
Charity challenges government on Avastin for wet AMD
April 24, 2012Sales and Marketing Lucentis, Novartis, Roche, avastin, off label, off-label, wet AMD
A leading patient group has called on the government to get to grips with the issue of off-label prescribing, as …
Quintiles appoints Tom Pike as new chief executive
April 24, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Quintiles, Tom Pike, biopharmaceutical
Quintiles, the biopharmaceutical services company, has appointed Tom Pike as its new chief executive, effective from 30 April. The appointment …
GSK to bring pharma plant in Sri Lanka online
April 24, 2012Manufacturing and Production BMS, GSK. Sri-Lanka, manufacturing and production
GlaxoSmithKline is due to open a newly-built manufacturing facility in Sri Lanka this week that is said to be the …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
